Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, Gülmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–33.

PubMed  Article  Google Scholar 

Brown HL. Medical and Surgical Innovations in Health Care. Obstet Gynecol. 2017;130(1):1–4.

PubMed  Article  Google Scholar 

Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? Placenta. 2014;35(Suppl):S20–5.

PubMed  Article  Google Scholar 

Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–4.

CAS  PubMed  Article  Google Scholar 

Romero R, Chaiworapongsa T. Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state. J Clin Invest. 2013;123(7):2775–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Palei AC, Spradley FT, Warrington JP, George EM, Granger JP. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol (Oxf). 2013;208(3):224–33.

CAS  Article  Google Scholar 

Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970–5.

CAS  PubMed  Article  Google Scholar 

Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;76(14):1690–702.

CAS  PubMed  Article  Google Scholar 

Goel A, Maski MR, Bajracharya S, Wenger JB, Zhang D, Salahuddin S, Shahul SS, Thadhani R, Seely EW, Karumanchi SA, Rana S. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period. Circulation. 2015;132(18):1726–33.

PubMed  PubMed Central  Article  Google Scholar 

Ramos JGL, Sass N, Costa SHM. Preeclampsia. Rev Bras Ginecol Obstet. 2017;39(9):496–512.

PubMed  Article  Google Scholar 

Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24(2):104–10.

CAS  PubMed  Article  Google Scholar 

Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62.e1-62.e10.

Article  Google Scholar 

Poon LC, Kametas NA, Pandeva I, Valencia C, Nicolaides KH. Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension. 2008;51(4):1027–33.

CAS  PubMed  Article  Google Scholar 

Jasović-Siveska E, Jasović V. Prediction of mild and severe preeclampsia with blood pressure measurements in first and second trimester of pregnancy. Ginekol Pol. 2011;82(11):845–50.

PubMed  Google Scholar 

A Ridder, V Giorgione, A Khalil, B Thilaganathan. Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function. Int J Mol Sci. 2019;20(13).

Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;30(5):742–9.

CAS  PubMed  Article  Google Scholar 

Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(2):138–46.

CAS  PubMed  Article  Google Scholar 

Poon LC, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH. Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks. Ultrasound Obstet Gynecol. 2009;34(2):142–8.

CAS  PubMed  Article  Google Scholar 

Sachan R, Patel ML, Vandana, Sachan P, Shyam R. Role of platelet count and mean platelet volume and red cell distribution width in the prediction of preeclampsia in early pregnancy. J Family Med Prim Care. 2021;10(2):838–43.

PubMed  PubMed Central  Article  Google Scholar 

Viana-Rojas JA, Rosas-Cabral A, Prieto-Macías J, Terrones-Saldívar MC, Arcos-Noguez P, Bermúdez-Gómez J, Martínez-Padilla LE, Sandoval-Valdez DA, Hernández-González F, Serrano-Díaz LC. Relation of red cell distribution width and mean platelet volume with the severity of preeclampsia. Rev Med Inst Mex Seguro Soc. 2017;55(2):176–81.

PubMed  Google Scholar 

Kim H, Lee JU, Kim S, Song S, Sim SJ. A Nanoplasmonic Biosensor for Ultrasensitive Detection of Alzheimer’s Disease Biomarker Using a Chaotropic Agent. ACS Sens. 2019;4(3):595–602.

CAS  PubMed  Article  Google Scholar 

Williams MD, Wheby MS. Anemia in pregnancy. Med Clin North Am. 1992;76(3):631–47.

CAS  PubMed  Article  Google Scholar 

Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019;124(7):1094–112.

CAS  PubMed  Article  Google Scholar 

Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31.

Article  Google Scholar 

Quitterer U, Fu X, Pohl A, Bayoumy KM, Langer A, AbdAlla S. Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers. Cell. 2019;176(1–2):318-333.e19.

CAS  PubMed  Article  Google Scholar 

Sahraravand M, Järvelä IY, Laitinen P, Tekay AH, Ryynänen M. The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of pregnancy. Placenta. 2011;32(12):999–1003.

CAS  PubMed  Article  Google Scholar 

Huppertz B, Meiri H, Gizurarson S, Osol G, Sammar M. Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia. Hum Reprod Update. 2013;19(4):391–405.

CAS  PubMed  Article  Google Scholar 

Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol. 2006;27(1):13–7.

CAS  PubMed  Article  Google Scholar 

N Moslemi Zadeh, F Naghshvar, S Peyvandi, P Gheshlaghi, S Ehetshami. PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?, ISRN Obstet Gynecol. 2012 (2012):263871.

Goetzinger KR, Zhong Y, Cahill AG, Odibo L, Macones GA, Odibo AO. Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia. J Ultrasound Med. 2013;32(9):1593–600.

PubMed  PubMed Central  Article  Google Scholar 

Park HJ, Shim SS, Cha DH. Combined Screening for Early Detection of Pre-Eclampsia. Int J Mol Sci. 2015;16(8):17952–74.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhang X, Huangfu Z, Shi F, Xiao Z. Predictive Performance of Serum β-hCG MoM Levels for Preeclampsia Screening: A Meta-Analysis. Front Endocrinol (Lausanne). 2021;12:619530.

Article  Google Scholar 

Hasija A, Balyan K, Debnath E, Kumar RVM. Prediction of hypertension in pregnancy in high risk women using maternal factors and serial placental profile in second and third trimester. Placenta. 2021;104:236–42.

PubMed  Article  Google Scholar 

Hodická Z, Bienertová-Vasků J, Ventruba P, Vasků A. Adrenocorticotropin hormone–possible marker of pregnancy pathologies. Ceska Gynekol. 2012;77(2):142–4.

PubMed  Google Scholar 

Lamarca B. Endothelial dysfunction An important mediator in the pathophysiology of hypertension during pre-eclampsia, Minerva. Ginecol. 2012;64(4):309–20.

CAS  Google Scholar 

Mistry HD, Ogalde MVH, Broughton Pipkin F, Escher G, Kurlak LO. Maternal, Fetal, and Placental Selectins in Women With Pre-eclampsia; Association With the Renin-Angiotensin-System. Front Med (Lausanne). 2020;7:270.

PubMed  PubMed Central  Article  Google Scholar 

Akhter T, Wikström AK, Larsson M, Larsson A, Wikström G, Naessen T. Serum Pentraxin 3 is associated with signs of arterial alteration in women with preeclampsia. Int J Cardiol. 2017;241:417–22.

PubMed  Article  Google Scholar 

Colmenares-Mejía CC, Quintero-Lesmes DC, Bautista-Niño PK, Guio Mahecha E, Beltrán Avendaño M, Díaz Martínez LA, Ortiz Serrano R, Páez Leal MC, Monterrosa Castro Á, Mesa Restrepo CM, Monsalve G, Sanín-Blair E, Saldarriaga W, Luna ML, Casas JP, Serrano Díaz N. Pentraxin-3 is a candidate biomarker on the spectrum of severity from pre-eclampsia to HELLP syndrome: GenPE study. Hyperten Res. 2020;43(9):884–91.

Article  CAS  Google Scholar 

Németh B, Murányi E, Hegyi P, Mátrai P, Szakács Z, Varjú P, Hamvas S, Tinusz B, Budán F, Czimmer J, Bérczi B, Erőss B, Gyöngyi Z, Kiss I. Asymmetric dimethylarginine levels in preeclampsia - Systematic review and meta-analysis. Placenta. 2018;69:57–63.

PubMed  Article  CAS  Google Scholar 

Akhter T, Wikström G, Larsson M, Bondesson U, Hedeland M, Naessen T. Dimethylarginines correlate to common carotid artery wall layer dimensions and cardiovascular risk factors in pregnant women with/without preeclampsia: A group comparative study. Eur J Obstet Gynecol Reprod Biol. 2021;258:288–93.

CAS  PubMed  Article  Google Scholar 

Garg P, Jaryal AK, Kachhawa G, Deepak KK, Kriplani A. Estimation of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in women with preeclampsia. Pregnancy Hypertens. 2018;14:245–51.

PubMed  Article  Google Scholar